Mercy Itohan Aboh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mercy Itohan Aboh has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Adeola Kola-Mustapha
Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmaceutical sciences, University of Ilorin, Ilorin, Nigeria
1 shared publication- Fahd Khalid-Salako
Sabanci University Nanotechnology Research and Application Centre
1 shared publication Ijeoma Ikeji
Department of Biological Science, Faculty of Science, Sciences University of Abuja, Federal Capital Territory, Abuja, Nigeria
1 shared publicationJaphet G. Yakubu
Department of Microbiology and Biotechnology, National Institute for Pharmaceutical Research and Development, Abuja, Nigeria
1 shared publicationJude U. Eze
Department of Microbiology and Biotechnology, National Institute for Pharmaceutical Research and Development, Abuja, Nigeria
1 shared publication- Katibi Oludolapo Sherifat
Sheffield Dermatology Research, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom; Dermatology Unit, Department of Paediatrics & Child Health, College of Health Sciences, University of Ilorin, Ilorin, Nigeria
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Sciencedomain International in Asian Journal of Advanced Research and Reports
- Vol. 19 (7) , 14-31
Complementary and Alternative Medicine: A Cross-sectional Study on Attitudes of Prospective Healthcare Professionals towards Herbal Medicines
Background: Herbal medicine remains integral to healthcare in many countries, yet its formal integration into conventional practice is still a challenge. This cross‑sectional study assessed attitudes toward herbal medicines among final‑year medical and pharmacy students in Nigeria across four domains: safety and efficacy, scientific validation, professional and educational relevance, and integration with conventional care. Methods: A total of 375 final‑year students from Nigeria’s six geopolitical zones completed a nine‑item Likert‑scale questionnaire. Data on personal use of herbal products, curriculum exposure, and institutional clinic availability were also collected. Descriptive and inferential statistical analyses were conducted. Results: A strong majority (88%) disagreed that herbal medicines lack efficacy, less than a quarter (24%) viewed them as inherently safe, but more than a third (36%) agreed that they require scientific testing before use, whilst more than three-quarters (83%) indicated that knowledge of herbal medicine is important for healthcare professionals. Close to three-quarters (70%) agreed that clinical care should integrate conventional medicine with herbal medicines, with pharmacy students (p < 0.001) and those exposed to the curricula (p < 0.001) showing more support for this view. Also, compared to the pharmacy students (51%), a higher proportion of the medical students (78%) agreed that herbal medications should not be employed for therapeutic purposes unless supported by scientific evidence (p < 0.001). Conclusion: While future Nigerian healthcare professionals recognize the therapeutic promise of herbal medicines and favour their educational inclusion and clinical integration, substantial caution persists regarding safety and the need for rigorous validation. These findings underscore the need for comprehensive, evidence‑based CAM curricula and clear regulatory frameworks to ensure safe, informed integration of herbal therapies into mainstream healthcare.
- 1 July 2025
- Published by Sciencedomain International in Asian Journal of Advanced Research and Reports
- Vol. 19 (7) , 14-31
Open AccessComplementary and Alternative Medicine: A Cross-sectional Study on Attitudes of Prospective Healthcare Professionals towards Herbal Medicines
Background: Herbal medicine remains integral to healthcare in many countries, yet its formal integration into conventional practice is still a challenge. This cross‑sectional study assessed attitudes toward herbal medicines among final‑year medical and pharmacy students in Nigeria across four domains: safety and efficacy, scientific validation, professional and educational relevance, and integration with conventional care. Methods: A total of 375 final‑year students from Nigeria’s six geopolitical zones completed a nine‑item Likert‑scale questionnaire. Data on personal use of herbal products, curriculum exposure, and institutional clinic availability were also collected. Descriptive and inferential statistical analyses were conducted. Results: A strong majority (88%) disagreed that herbal medicines lack efficacy, less than a quarter (24%) viewed them as inherently safe, but more than a third (36%) agreed that they require scientific testing before use, whilst more than three-quarters (83%) indicated that knowledge of herbal medicine is important for healthcare professionals. Close to three-quarters (70%) agreed that clinical care should integrate conventional medicine with herbal medicines, with pharmacy students (p < 0.001) and those exposed to the curricula (p < 0.001) showing more support for this view. Also, compared to the pharmacy students (51%), a higher proportion of the medical students (78%) agreed that herbal medications should not be employed for therapeutic purposes unless supported by scientific evidence (p < 0.001). Conclusion: While future Nigerian healthcare professionals recognize the therapeutic promise of herbal medicines and favour their educational inclusion and clinical integration, substantial caution persists regarding safety and the need for rigorous validation. These findings underscore the need for comprehensive, evidence‑based CAM curricula and clear regulatory frameworks to ensure safe, informed integration of herbal therapies into mainstream healthcare.
- Open Access
- 22 December 2022
- Published by African Traditional Herbal Medicine Supporters Initiative (ATHMSI) in African Journal of Infectious Diseases
- Vol. 17 (1) , 74
ANTI-FUNGAL ACTIVITY OF ACALYPHA WILKESIANA: A PRELIMINARY STUDY OF FUNGAL ISOLATES OF CLINICAL SIGNIFICANCE
Background: Acalypha wilkesiana (AW), a popular medicinal plant has been used in traditional medicine to treat a variety of skin disorders including pityriasis versicolor and seborrheic dermatitis. As a prelude to clinical trials in humans, an experimental study was carried out to determine the spectrum of antifungal activity of 2 variants of the Acalypha wilkesiana plant. Materials and Methods: The ethanol extract and herbal cream formulation of the dried leaves of 2 cultivars (Macrophylla & Hoffmani) of Acalypha wilkesiana were investigated for in-vitro antifungal activity by disc diffusion and micro-broth dilution techniques. Organisms tested were typed cultures of Malassezia furfur, Candida albicans and Trichophyton rubrum; and clinical strains of Microsporum canis and Epidermophyton floccosum. Results: Both cultivars (Macrophylla and Hoffmanii) of the plant showed good activity against all the fungi tested except Microsporum canis (8.0±0.00; 7.00±0.00 mm). The greatest activity was observed against Trichophyton rubrum (22.0±0.00; 24.00±0.00 mm). The Minimum Inhibitory Concentration (MIC) of the crude extract ranged between 0.25 and 8 mg/ml for all organisms, while that of the herbal cream was 0.31-8mg/ml. The lowest MIC was seen with Candida albicans for both varieties of the plant. The Acalypha wilkesiana Hoffmanii demonstrated a greater activity against Candida albicans and Malassezia furufur than the A. wilkesiana Macrophylla. Conclusion: This study reveals Acalypha wilkesiana leaf extract has potential for development as a cream that can be used to treat superficial fungal skin infections.
- 22 December 2022
- Published by African Traditional Herbal Medicine Supporters Initiative (ATHMSI) in African Journal of Infectious Diseases
- Vol. 17 (1) , 74
Open AccessANTI-FUNGAL ACTIVITY OF ACALYPHA WILKESIANA: A PRELIMINARY STUDY OF FUNGAL ISOLATES OF CLINICAL SIGNIFICANCE
Background: Acalypha wilkesiana (AW), a popular medicinal plant has been used in traditional medicine to treat a variety of skin disorders including pityriasis versicolor and seborrheic dermatitis. As a prelude to clinical trials in humans, an experimental study was carried out to determine the spectrum of antifungal activity of 2 variants of the Acalypha wilkesiana plant. Materials and Methods: The ethanol extract and herbal cream formulation of the dried leaves of 2 cultivars (Macrophylla & Hoffmani) of Acalypha wilkesiana were investigated for in-vitro antifungal activity by disc diffusion and micro-broth dilution techniques. Organisms tested were typed cultures of Malassezia furfur, Candida albicans and Trichophyton rubrum; and clinical strains of Microsporum canis and Epidermophyton floccosum. Results: Both cultivars (Macrophylla and Hoffmanii) of the plant showed good activity against all the fungi tested except Microsporum canis (8.0±0.00; 7.00±0.00 mm). The greatest activity was observed against Trichophyton rubrum (22.0±0.00; 24.00±0.00 mm). The Minimum Inhibitory Concentration (MIC) of the crude extract ranged between 0.25 and 8 mg/ml for all organisms, while that of the herbal cream was 0.31-8mg/ml. The lowest MIC was seen with Candida albicans for both varieties of the plant. The Acalypha wilkesiana Hoffmanii demonstrated a greater activity against Candida albicans and Malassezia furufur than the A. wilkesiana Macrophylla. Conclusion: This study reveals Acalypha wilkesiana leaf extract has potential for development as a cream that can be used to treat superficial fungal skin infections.
- 22 December 2021
- Published by Sciencedomain International in Journal of Advances in Microbiology
- p. 128-134
Antifungal Potential of Some Nigerian Indigenous Plants: A Remedy for Candidiasis
Background: Invasive candidiasis has been recognized as a major cause of mortality and morbidity in hospital settings across the globe. Aside from C. albicans, other Candida species (C. glabarata, C. parapsilosis, and C. tropicalis) associated with invasive candidiasis have been reported as a public health challenge. Objective: This study aimed to evaluate the antifungal activities of extracts of some indigenous plants using the agar disc diffusion method. Methods: Fresh samples of the plant parts were collected, identified, air dried, pulverized and extracted using standard methods. The extracts were screened against clinical isolates of C. albicans, C. glabarata, C. parapsilosis and C. tropicalis using agar disc diffusion method. Results: All plant extracts exhibited varying inhibition zones ranging from 8.0 - 24.0 mm against the tested isolates. Fractions of Acalypha wilkesiana Macrophylla (AWRF5) showed the lowest activities against all the test isolates with zones of inhibition ranging from 10.0-13.0 mm while AWRF6 fraction of the same plant demonstrated highest antifungal activities against all the test isolates with zones of inhibition ranging from 14.0-24 mm followed by fractions of Acalypha wilkesiana Hoffmanii (AWGF6), which demonstrated high (14.0 - 20.0 mm) antifungal activities. Conclusion: The Plants understudied possessed antifungal potentials and can serve as lead in the development of phytomedicines to combat candidiasis decrease medical as well as financial burden, hence improving the management of cirrhotic patients. These predictors, however, need further work to validate reliability.
- 22 December 2021
- Published by Sciencedomain International in Journal of Advances in Microbiology
- p. 128-134
Antifungal Potential of Some Nigerian Indigenous Plants: A Remedy for Candidiasis
Background: Invasive candidiasis has been recognized as a major cause of mortality and morbidity in hospital settings across the globe. Aside from C. albicans, other Candida species (C. glabarata, C. parapsilosis, and C. tropicalis) associated with invasive candidiasis have been reported as a public health challenge. Objective: This study aimed to evaluate the antifungal activities of extracts of some indigenous plants using the agar disc diffusion method. Methods: Fresh samples of the plant parts were collected, identified, air dried, pulverized and extracted using standard methods. The extracts were screened against clinical isolates of C. albicans, C. glabarata, C. parapsilosis and C. tropicalis using agar disc diffusion method. Results: All plant extracts exhibited varying inhibition zones ranging from 8.0 - 24.0 mm against the tested isolates. Fractions of Acalypha wilkesiana Macrophylla (AWRF5) showed the lowest activities against all the test isolates with zones of inhibition ranging from 10.0-13.0 mm while AWRF6 fraction of the same plant demonstrated highest antifungal activities against all the test isolates with zones of inhibition ranging from 14.0-24 mm followed by fractions of Acalypha wilkesiana Hoffmanii (AWGF6), which demonstrated high (14.0 - 20.0 mm) antifungal activities. Conclusion: The Plants understudied possessed antifungal potentials and can serve as lead in the development of phytomedicines to combat candidiasis decrease medical as well as financial burden, hence improving the management of cirrhotic patients. These predictors, however, need further work to validate reliability.
- 2 March 2021
- Published by Sciencedomain International in European Journal of Nutrition & Food Safety
- p. 70-78
Effect of Abiotic Factors on the Antifungal Activity of Lactobacillus Strains Isolated from Commercial Dairy and Fermented Foods from Federal Capital Territory, Nigeria
Increasing consumer demand for natural products have renewed food industry attention in bio preservation. Lactic acid bacteria are of particular interest as effective alternative to chemical preservation because of their food grade status. This work explores the effect of antifungal compounds produced by isolates of Lactobacillus sp on some selected pathogenic fungi growth. Samples of diary and fermented products were purchased from commercial vendors within the Federal Capital Territory (FCT) and screened for the presence of Lactobacillus sp. The Lactobacillus sp isolated were screened for antifungal activity against Aspergillus fumigatus, Candida albicans and Trichophyton rubrum using a dual culture assay. Strains with antifungal activity were identified and the fungal inhibitory activity was further evaluated. The effect of abiotic factors on the antifungal activity was evaluated by overlay assay under different temperature and pH. Majority of the identified isolates belonged to the genus Lactobacillus. Lactobacillus sp. produced antifungal compounds under different temperatures (25ºC, 30ºC and 37ºC). The antifungal compounds produced by Lactobacillus strains showed greater inhibitory activity on Aspergillus fumigatus. At 30ºC the percentage zones of inhibition range were 44.4%- 60.4%. All isolates showed stronger antifungal activity when grown at pH 4.0 and 5.0. At a pH 2.0 there was a total inhibition of fungal growth however, there was no inhibition of fungal growth at the pH 7.0. Lactic acid bacteria can be employed as effective alternative to chemical preservatives in food. Temperature and pH of the culture medium could influence the production of antifungal compounds by lactic acid bacteria.
- 2 March 2021
- Published by Sciencedomain International in European Journal of Nutrition & Food Safety
- p. 70-78
Effect of Abiotic Factors on the Antifungal Activity of Lactobacillus Strains Isolated from Commercial Dairy and Fermented Foods from Federal Capital Territory, Nigeria
Increasing consumer demand for natural products have renewed food industry attention in bio preservation. Lactic acid bacteria are of particular interest as effective alternative to chemical preservation because of their food grade status. This work explores the effect of antifungal compounds produced by isolates of Lactobacillus sp on some selected pathogenic fungi growth. Samples of diary and fermented products were purchased from commercial vendors within the Federal Capital Territory (FCT) and screened for the presence of Lactobacillus sp. The Lactobacillus sp isolated were screened for antifungal activity against Aspergillus fumigatus, Candida albicans and Trichophyton rubrum using a dual culture assay. Strains with antifungal activity were identified and the fungal inhibitory activity was further evaluated. The effect of abiotic factors on the antifungal activity was evaluated by overlay assay under different temperature and pH. Majority of the identified isolates belonged to the genus Lactobacillus. Lactobacillus sp. produced antifungal compounds under different temperatures (25ºC, 30ºC and 37ºC). The antifungal compounds produced by Lactobacillus strains showed greater inhibitory activity on Aspergillus fumigatus. At 30ºC the percentage zones of inhibition range were 44.4%- 60.4%. All isolates showed stronger antifungal activity when grown at pH 4.0 and 5.0. At a pH 2.0 there was a total inhibition of fungal growth however, there was no inhibition of fungal growth at the pH 7.0. Lactic acid bacteria can be employed as effective alternative to chemical preservatives in food. Temperature and pH of the culture medium could influence the production of antifungal compounds by lactic acid bacteria.
- Open Access
- 8 February 2021
- Published by Sciencedomain International in Journal of Advances in Microbiology
- p. 77-83
Comparative Study on Effectiveness of Commercial Antibiotic Discs in Federal Capital Territory (FCT), Nigeria
Clinically, antimicrobial susceptibility testing results provide guidance in the choice of antimicrobial agents in patient care. The accuracy of results from antimicrobial susceptibility testing can be affected by multiple factors including the media, antimicrobial discs or preparations, inoculum’s size, plate reading and incubation conditions. Misleading results from antimicrobial susceptibility test leads to the indiscriminate and irrational use of antibiotics and have impacted grossly to the global challenge of antimicrobial resistance. The objectives of this study were to compare the efficacy of different brands of locally and foreign manufactured multi-antibiotic discs on bacteria and assess any significant variation. Two brands each of locally and foreign manufactured multi-antibiotic discs were purchased from retail stores within the FCT. The antibacterial susceptibility of Staphylococcus aureus ATCC 25923, Salmonella typhi ATCC 9150, Klebsiella pneumonia, Pseudomonas aeruginosa, Bacillus subtilis, Escherichia coli ATCC 25922 and Streptococcus pyogenes were carried out using agar diffusion method. There were differences between the diameter zones of inhibition produced by the local brands and the foreign brands of antibiotic discs. Amoxicillin/clavulanic acid (30 µg) disc produced the highest variation within the four brands with zones of inhibition range 12.0 – 20.0 mm against the test organisms. There is need for regulatory bodies like NAFDAC and SON to routinely validate and assess the qualities of these products in the market.
- 8 February 2021
- Published by Sciencedomain International in Journal of Advances in Microbiology
- p. 77-83
Open AccessComparative Study on Effectiveness of Commercial Antibiotic Discs in Federal Capital Territory (FCT), Nigeria
Clinically, antimicrobial susceptibility testing results provide guidance in the choice of antimicrobial agents in patient care. The accuracy of results from antimicrobial susceptibility testing can be affected by multiple factors including the media, antimicrobial discs or preparations, inoculum’s size, plate reading and incubation conditions. Misleading results from antimicrobial susceptibility test leads to the indiscriminate and irrational use of antibiotics and have impacted grossly to the global challenge of antimicrobial resistance. The objectives of this study were to compare the efficacy of different brands of locally and foreign manufactured multi-antibiotic discs on bacteria and assess any significant variation. Two brands each of locally and foreign manufactured multi-antibiotic discs were purchased from retail stores within the FCT. The antibacterial susceptibility of Staphylococcus aureus ATCC 25923, Salmonella typhi ATCC 9150, Klebsiella pneumonia, Pseudomonas aeruginosa, Bacillus subtilis, Escherichia coli ATCC 25922 and Streptococcus pyogenes were carried out using agar diffusion method. There were differences between the diameter zones of inhibition produced by the local brands and the foreign brands of antibiotic discs. Amoxicillin/clavulanic acid (30 µg) disc produced the highest variation within the four brands with zones of inhibition range 12.0 – 20.0 mm against the test organisms. There is need for regulatory bodies like NAFDAC and SON to routinely validate and assess the qualities of these products in the market.
- Open Access
- 21 January 2021
- Published by African Traditional Herbal Medicine Supporters Initiative (ATHMSI) in African Journal of Infectious Diseases
- Vol. 16 (1) , 21-30
ANTI-FUNGAL ACTIVITY OF ACALYPHA WILKESIANA: A PRELIMINARY STUDY OF FUNGAL ISOLATES OF CLINICAL SIGNIFICANCE
Acalypha wilkesiana (AW), a popular medicinal plant has been used in traditional medicine to treat a variety of skin disorders including pityriasis versicolor and seborrheic dermatitis. As a prelude to clinical trials in humans, an experimental study was carried out to determine the spectrum of antifungal activity of 2 variants of the Acalypha wilkesiana plant. Materials and Methods: The ethanol extract and herbal cream formulation of the dried leaves of 2 cultivars (Macrophylla & Hoffmani) of Acalypha wilkesiana were investigated for in-vitro antifungal activity by disc diffusion and micro-broth dilution techniques. Organisms tested were typed cultures of Malassezia furfur, Candida albicans and Trichophyton rubrum; and clinical strains of Microsporum canis and Epidermophyton floccosum. Results: Both cultivars (Macrophylla and Hoffmanii) of the plant showed good activity against all the fungi tested except Microsporum canis (8.0±0.00; 7.00±0.00 mm). The greatest activity was observed against Trichophyton rubrum (22.0±0.00; 24.00±0.00 mm) while Candida albicans showed the least activity (15.0±0.00; 18.00±0.57 mm). The Minimum Inhibitory Concentration (MIC) of the crude extract ranged between 0.25 and 8 mg/ml for all organisms, while that of the herbal cream was 0.31-8mg/ml. The lowest MIC was seen with Candida albicans for both varieties of the plant. The Acalypha wilkesiana Hoffmanii demonstrated a greater activity against Candida albicans and Malassezia furufur than the A. wilkesiana (Macrophylla). Conclusion: This study reveals Acalypha wilkesiana leaf extract has potential for development as a cream that can be used to treat superficial fungal skin infections.
- 21 January 2021
- Published by African Traditional Herbal Medicine Supporters Initiative (ATHMSI) in African Journal of Infectious Diseases
- Vol. 16 (1) , 21-30
Open AccessANTI-FUNGAL ACTIVITY OF ACALYPHA WILKESIANA: A PRELIMINARY STUDY OF FUNGAL ISOLATES OF CLINICAL SIGNIFICANCE
Acalypha wilkesiana (AW), a popular medicinal plant has been used in traditional medicine to treat a variety of skin disorders including pityriasis versicolor and seborrheic dermatitis. As a prelude to clinical trials in humans, an experimental study was carried out to determine the spectrum of antifungal activity of 2 variants of the Acalypha wilkesiana plant. Materials and Methods: The ethanol extract and herbal cream formulation of the dried leaves of 2 cultivars (Macrophylla & Hoffmani) of Acalypha wilkesiana were investigated for in-vitro antifungal activity by disc diffusion and micro-broth dilution techniques. Organisms tested were typed cultures of Malassezia furfur, Candida albicans and Trichophyton rubrum; and clinical strains of Microsporum canis and Epidermophyton floccosum. Results: Both cultivars (Macrophylla and Hoffmanii) of the plant showed good activity against all the fungi tested except Microsporum canis (8.0±0.00; 7.00±0.00 mm). The greatest activity was observed against Trichophyton rubrum (22.0±0.00; 24.00±0.00 mm) while Candida albicans showed the least activity (15.0±0.00; 18.00±0.57 mm). The Minimum Inhibitory Concentration (MIC) of the crude extract ranged between 0.25 and 8 mg/ml for all organisms, while that of the herbal cream was 0.31-8mg/ml. The lowest MIC was seen with Candida albicans for both varieties of the plant. The Acalypha wilkesiana Hoffmanii demonstrated a greater activity against Candida albicans and Malassezia furufur than the A. wilkesiana (Macrophylla). Conclusion: This study reveals Acalypha wilkesiana leaf extract has potential for development as a cream that can be used to treat superficial fungal skin infections.